Vera Therapeutics | DEFA14A:其他
05/03 16:09 (美东)
Vera Therapeutics | 4:持股变动声明-高管 Young Joseph R
04/12 16:03 (美东)
Vera Therapeutics | 4:持股变动声明-高管 Grant Sean
04/05 21:34 (美东)
Vera Therapeutics | 4:持股变动声明-高管 Grant Sean
04/05 21:29 (美东)
Vera Therapeutics | ARS:年度报告
04/04 06:05 (美东)
Vera Therapeutics | DEF 14A:股东委托书决议
04/03 17:04 (美东)
Vera Therapeutics | DEFA14A:其他
04/03 17:04 (美东)
Vera Therapeutics | 144:拟议出售证券
04/03 16:22 (美东)
Vera Therapeutics | S-8:员工福利计划证券登记
03/27 16:21 (美东)
Vera Therapeutics | 10-K:年度报表
03/27 14:53 (美东)
Vera Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-Dr. Maha Katabi (“Katabi”)(5.4%),Sofinnova Venture Partners X, L.P. (“SVP X”)(5.3%)等
03/26 20:00 (美东)
Vera Therapeutics | 4:持股变动声明-董事 Katabi Maha
03/25 21:50 (美东)
Vera Therapeutics | 144:拟议出售证券
03/21 16:58 (美东)
Vera Therapeutics | 8-K:Vera Therapeutics 提供最新业务并报告 2023 年第四季度和全年财务业绩
03/20 07:32 (美东)
Vera Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-Sofinnova Venture Partners X, L.P. (“SVP X”)(6.9%),Sofinnova Management X, L.P. (“SM X LP”)(6.9%)等
02/20 19:15 (美东)
Vera Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Commodore Capital LP(11.3%),Commodore Capital Master LP(11.3%)
02/14 18:06 (美东)
Vera Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Commodore Capital LP(12.3%),Commodore Capital Master LP(12.3%)
02/14 18:00 (美东)
Vera Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Citadel Securities LLC(0.1%),Citadel Securities Group LP(0.1%)等
02/14 17:04 (美东)
Vera Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Ares Trading SA(3.6%),Merck Serono SA, Coinsins, Switzerland, an affiliate of Merck KGaA, Darmstadt, Germany(3.6%)等
02/14 15:25 (美东)
Vera Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Kynam Capital Management, LP(8.22%),Kynam Capital Management GP, LLC(8.22%)等
02/14 12:52 (美东)
暂无数据
暂无数据